**Abstract**

**Background**: Problems of sleep initiation and maintenance occur in 15% to 25% of children and adolescents. Insomnia refers to loss of daytime function resulting from unsatisfactory sleep. The symptoms of insomnia include fatigue, inattention, irritability, lack of energy, and anxiety.

**Objective:** The efficacy and safety of sansoninto (SNT), Japnese herbal medicine, was examined for insomnia in child and adolescent patients.

**Methods:** Thirty-one children and adolescents with sleep disturbance meeting DSM-IV-TR diagnostic criteria for psychiatric disorders were treated openly for four weeks with SNT (2.5 -- 5 g) at bedtime. Efficacy was analyzed using a repeated measures methodology. The primary outcome was the Pittsburgh Sleep Quality Index (PSQI). The secondary outcomes were the Insomnia Severity Index (ISI), Athens Insomnia Scale (AIS), Clinical Global Impression-Improvement (CGI-I), and change of dosage of benzodiazepine hypnotics (diazepam equivalent).

**Results:** Significant symptom reduction was observed on all parameters (PSQI, ISI, AIS, CGI-I, and dosage of benzodiazepine hypnotics). No withdrawal involved treatment-related adverse events.

**Conclusion**: Data from this 4-week open-label study suggests SNT was an effective and generally well tolerated treatment for insomnia symptoms in this sample of child and adolescent patients with insomnia.
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